Xeris Biopharma Holdings Inc (XERS) receives an Outperform rating from Oppenheimer
Xeris Biopharma Holdings Inc’s recently made public that its Director Schmid John P. acquired Company’s shares for reported $9720.0 on Mar 14 ’24. In the deal valued at $2.16 per share,4,500 shares were bought. As a result of this transaction, Schmid John P. now holds 11,000 shares worth roughly $19250.0. Then, SHERMAN JEFFREY W bought […]
XERS Stock Sees Decline of Approximately -1.12% in Last Five Days
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Xeris Biopharma Holdings Inc shares valued at $9,720 were purchased by Schmid John P. on Mar 14 ’24. At $2.16 per share, Schmid John P. acquired 4,500 shares. The insider’s holdings grew to 11,000 shares worth approximately […]
Xeris Biopharma Holdings Inc (XERS) Becoming More Attractive for Investors
Xeris Biopharma Holdings Inc’s recently made public that its Director Schmid John P. acquired Company’s shares for reported $9720.0 on Mar 14 ’24. In the deal valued at $2.16 per share,4,500 shares were bought. As a result of this transaction, Schmid John P. now holds 11,000 shares worth roughly $19140.0. Then, SHERMAN JEFFREY W bought […]
Taking a look at what insiders are doing to gauge the Xeris Biopharma Holdings Inc (XERS)’s direction
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Xeris Biopharma Holdings Inc shares valued at $9,720 were purchased by Schmid John P. on Mar 14 ’24. At $2.16 per share, Schmid John P. acquired 4,500 shares. The insider’s holdings […]
Xeris Biopharma Holdings Inc [XERS] Investment Appeal on the Rise
Xeris Biopharma Holdings Inc’s recently made public that its Director Schmid John P. acquired Company’s shares for reported $9720.0 on Mar 14 ’24. In the deal valued at $2.16 per share,4,500 shares were bought. As a result of this transaction, Schmid John P. now holds 11,000 shares worth roughly $21010.0. Then, SHERMAN JEFFREY W bought […]
Xeris Biopharma Holdings Inc [XERS] Director makes an insider purchase of 4,500 shares worth 9720.0.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Xeris Biopharma Holdings Inc shares valued at $9,720 were purchased by Schmid John P. on Mar 14 ’24. At $2.16 per share, Schmid John P. acquired 4,500 shares. The insider’s holdings grew to 11,000 shares worth approximately […]
Understanding the Risks of Investing in Xeris Biopharma Holdings Inc (XERS)
Xeris Biopharma Holdings Inc’s recent filing unveils that its Director Schmid John P. acquired Company’s shares for reported $9720.0 on Mar 14 ’24. In the deal valued at $2.16 per share,4,500 shares were bought. As a result of this transaction, Schmid John P. now holds 11,000 shares worth roughly $22440.0. Then, SHERMAN JEFFREY W bought […]